Abstract
Influenza virus-infected cells are induced to undergo apoptosis and become susceptible to phagocytosis. Data from our in vitro and in vivo experiments have suggested that 1) alveolar macrophages and neutrophils phagocytose influenza virus-infected cells in an apoptosis-dependent manner; 2) the membrane phospholipid phosphatidylserine and viral neuraminidase-processed carbohydrates at the surface of target cells and phagocytes, respectively, are involved in the association of the two types of cells; and 3) phagocytic elimination of virus-infected cells leads to a reduction in the pathogenesis of influenza. These findings could lead to the development of a novel antiviral agent against influenza.
Keywords: Apoptosis, influenza virus, innate immunity, macrophages, neutrophils, phagocytosis, phosphatidylserine
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry
Title: Mechanisms and Consequences of Phagocytosis of Influenza Virus-Infected Cells
Volume: 7 Issue: 2
Author(s): Yoshinobu Nakanishi, Yumi Hashimoto, Takenori Takizawa and Akiko Shiratsuchi
Affiliation:
Keywords: Apoptosis, influenza virus, innate immunity, macrophages, neutrophils, phagocytosis, phosphatidylserine
Abstract: Influenza virus-infected cells are induced to undergo apoptosis and become susceptible to phagocytosis. Data from our in vitro and in vivo experiments have suggested that 1) alveolar macrophages and neutrophils phagocytose influenza virus-infected cells in an apoptosis-dependent manner; 2) the membrane phospholipid phosphatidylserine and viral neuraminidase-processed carbohydrates at the surface of target cells and phagocytes, respectively, are involved in the association of the two types of cells; and 3) phagocytic elimination of virus-infected cells leads to a reduction in the pathogenesis of influenza. These findings could lead to the development of a novel antiviral agent against influenza.
Export Options
About this article
Cite this article as:
Nakanishi Yoshinobu, Hashimoto Yumi, Takizawa Takenori and Shiratsuchi Akiko, Mechanisms and Consequences of Phagocytosis of Influenza Virus-Infected Cells, Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry 2008; 7 (2) . https://dx.doi.org/10.2174/187152308784533122
DOI https://dx.doi.org/10.2174/187152308784533122 |
Print ISSN 1871-5230 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-614X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
The Role of PKR as a Potential Target for Treating Cardiovascular Diseases
Current Cardiology Reviews The Prevention of Adverse Drug Reactions in Older Subjects
Current Drug Metabolism Sesbania: A Prospective Candidate to be Excavated for Anticancer Drugs
The Natural Products Journal A New Strategy to Target Acute Myeloid Leukemia Stem and Progenitor Cells Using Chidamide, a Histone Deacetylase Inhibitor
Current Cancer Drug Targets Leptin: A Promising Therapeutic Target with Pleiotropic Action Besides Body Weight Regulation
Current Drug Targets Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism
Current Hypertension Reviews Neuropeptides as Therapeutic Approach to Autoimmune Diseases
Current Pharmaceutical Design Epigenetic Regulation of Regulatory T Cells in Kidney Disease and Transplantation
Current Gene Therapy Targeting the Tumor Microenvironment by Intervention in Interleukin-1 Biology
Current Pharmaceutical Design Role of Genetics and Epigenetics in Mucosal, Uveal, and Cutaneous Melanomagenesis
Anti-Cancer Agents in Medicinal Chemistry Therapeutic Exploitation of Endogenous Anti-Inflammatory Mechanisms:Old and New Leads
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Enriching One’s Environment in the Face of Cognitive and Functional Loss
Current Neurovascular Research The Role of Natural Products in the Discovery of New Drug Candidates for the Treatment of Neurodegenerative Disorders II: Alzheimers Disease
CNS & Neurological Disorders - Drug Targets Linking Inflammation to Cell Cycle Progression
Current Pharmaceutical Design Current Evidence on the Evaluation and Management of Fever Without a Source in Infants Aged 0-90 Days: A Review
Reviews on Recent Clinical Trials Systemic Application of Anti-inflammatory Agents in Periodontal Treatment
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) Nanoparticle-based Cerebral Drug-Delivery Systems and Antiangiogenic Approach in Gliomas Treatment
Recent Patents on Nanotechnology Toll-Like Receptor (TLR) Response Tolerance: A Key Physiological “ Damage Limitation ” Effect and an Important Potential Opportunity for Therapy
Current Medicinal Chemistry In Vitro and In Vivo Neuroprotective Effects of Etifoxine in β-Amyloidinduced Toxicity Models
CNS & Neurological Disorders - Drug Targets A Review on Clinical Management and Pharmacological Therapy on Hereditary Haemorrhagic Telangiectasia (HHT)
Current Vascular Pharmacology